ALZHEIMERS RES THER 润色咨询

Alzheimers Research & Therapy

出版年份:暂无数据 年文章数:995 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:3.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2206165, encodeId=cc9d220616512, content=三天就peer review了,现在peer review一个月了也没有消息,这是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a9099638, createdName=ms4000001167903499, createdTime=Thu May 23 10:45:40 CST 2024, time=2024-05-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169145, encodeId=8c95216914575, content=有人能说下投稿状态的变化吗,里边是peer review,外边是editor appointed,多久会变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18152413432, createdName=1237f2c6m31暂无昵称, createdTime=Fri Nov 17 16:38:01 CST 2023, time=2023-11-17, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2125950, encodeId=b778212595012, content=编辑收到外审报告,两个月了迟迟不做决定,有知道原因的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Fri Apr 14 18:01:21 CST 2023, time=2023-04-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145376, encodeId=545521453e621, content=9分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Thu Jun 29 08:32:45 CST 2023, time=2023-06-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126276, encodeId=c4e121262e6f8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长,结果是好的,继续努力。 Version 2 created 24 Jan, 2023 Editorial decision: Accepted On 13 Mar, 2023 Reviews received Received 03 Feb, 2023 Reviewers agreed On 27 Jan, 2023 Reviewers invited Invitations sent on 26 Jan, 2023 Submission checks complete On 26 Jan, 2023 Submitted to Alzheimer's Research & Therapy On 24 Jan, 2023 Preprint in production at Research Square Version 1 posted 22 Jul, 2022 No new comments on your preprint Editorial decision: Major revision On 28 Dec, 2022 Reviewers agreed On 21 Dec, 2022 Reviews received Received 29 Oct, 2022 Reviewers agreed On 19 Oct, 2022 Reviewers invited Invitations sent on 25 Jul, 2022 Submission checks complete On 20 Jul, 2022 Editor assigned On 20 Jul, 2022 First submitted to Alzheimer's Research & Therapy, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:22:28 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126275, encodeId=f53321262e5ed, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:19:14 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126273, encodeId=4cf221262e346, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长了,结果是好的,继续努力<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:17:34 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1237034, encodeId=e465123e03421, content=偏重的研究方向:认知<br>经验分享:请问投稿之前需要先查重吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=XW-Tong, createdTime=Sun Aug 07 09:16:03 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104694, encodeId=8ee21104694ef, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104693, encodeId=bd7d110469301, content=如何回复期刊编辑的意见?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2024-05-23 ms4000001167903499 来自山东省

    三天就peer review了,现在peer review一个月了也没有消息,这是正常的吗

    7

    展开7条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2206165, encodeId=cc9d220616512, content=三天就peer review了,现在peer review一个月了也没有消息,这是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a9099638, createdName=ms4000001167903499, createdTime=Thu May 23 10:45:40 CST 2024, time=2024-05-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169145, encodeId=8c95216914575, content=有人能说下投稿状态的变化吗,里边是peer review,外边是editor appointed,多久会变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18152413432, createdName=1237f2c6m31暂无昵称, createdTime=Fri Nov 17 16:38:01 CST 2023, time=2023-11-17, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2125950, encodeId=b778212595012, content=编辑收到外审报告,两个月了迟迟不做决定,有知道原因的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Fri Apr 14 18:01:21 CST 2023, time=2023-04-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145376, encodeId=545521453e621, content=9分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Thu Jun 29 08:32:45 CST 2023, time=2023-06-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126276, encodeId=c4e121262e6f8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长,结果是好的,继续努力。 Version 2 created 24 Jan, 2023 Editorial decision: Accepted On 13 Mar, 2023 Reviews received Received 03 Feb, 2023 Reviewers agreed On 27 Jan, 2023 Reviewers invited Invitations sent on 26 Jan, 2023 Submission checks complete On 26 Jan, 2023 Submitted to Alzheimer's Research & Therapy On 24 Jan, 2023 Preprint in production at Research Square Version 1 posted 22 Jul, 2022 No new comments on your preprint Editorial decision: Major revision On 28 Dec, 2022 Reviewers agreed On 21 Dec, 2022 Reviews received Received 29 Oct, 2022 Reviewers agreed On 19 Oct, 2022 Reviewers invited Invitations sent on 25 Jul, 2022 Submission checks complete On 20 Jul, 2022 Editor assigned On 20 Jul, 2022 First submitted to Alzheimer's Research & Therapy, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:22:28 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126275, encodeId=f53321262e5ed, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:19:14 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126273, encodeId=4cf221262e346, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长了,结果是好的,继续努力<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:17:34 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1237034, encodeId=e465123e03421, content=偏重的研究方向:认知<br>经验分享:请问投稿之前需要先查重吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=XW-Tong, createdTime=Sun Aug 07 09:16:03 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104694, encodeId=8ee21104694ef, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104693, encodeId=bd7d110469301, content=如何回复期刊编辑的意见?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2023-11-17 1237f2c6m31暂无昵称 来自德国

    有人能说下投稿状态的变化吗,里边是peer review,外边是editor appointed,多久会变化呢

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2206165, encodeId=cc9d220616512, content=三天就peer review了,现在peer review一个月了也没有消息,这是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a9099638, createdName=ms4000001167903499, createdTime=Thu May 23 10:45:40 CST 2024, time=2024-05-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169145, encodeId=8c95216914575, content=有人能说下投稿状态的变化吗,里边是peer review,外边是editor appointed,多久会变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18152413432, createdName=1237f2c6m31暂无昵称, createdTime=Fri Nov 17 16:38:01 CST 2023, time=2023-11-17, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2125950, encodeId=b778212595012, content=编辑收到外审报告,两个月了迟迟不做决定,有知道原因的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Fri Apr 14 18:01:21 CST 2023, time=2023-04-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145376, encodeId=545521453e621, content=9分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Thu Jun 29 08:32:45 CST 2023, time=2023-06-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126276, encodeId=c4e121262e6f8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长,结果是好的,继续努力。 Version 2 created 24 Jan, 2023 Editorial decision: Accepted On 13 Mar, 2023 Reviews received Received 03 Feb, 2023 Reviewers agreed On 27 Jan, 2023 Reviewers invited Invitations sent on 26 Jan, 2023 Submission checks complete On 26 Jan, 2023 Submitted to Alzheimer's Research & Therapy On 24 Jan, 2023 Preprint in production at Research Square Version 1 posted 22 Jul, 2022 No new comments on your preprint Editorial decision: Major revision On 28 Dec, 2022 Reviewers agreed On 21 Dec, 2022 Reviews received Received 29 Oct, 2022 Reviewers agreed On 19 Oct, 2022 Reviewers invited Invitations sent on 25 Jul, 2022 Submission checks complete On 20 Jul, 2022 Editor assigned On 20 Jul, 2022 First submitted to Alzheimer's Research & Therapy, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:22:28 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126275, encodeId=f53321262e5ed, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:19:14 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126273, encodeId=4cf221262e346, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长了,结果是好的,继续努力<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:17:34 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1237034, encodeId=e465123e03421, content=偏重的研究方向:认知<br>经验分享:请问投稿之前需要先查重吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=XW-Tong, createdTime=Sun Aug 07 09:16:03 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104694, encodeId=8ee21104694ef, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104693, encodeId=bd7d110469301, content=如何回复期刊编辑的意见?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2023-04-14 ms8000001190739114 来自上海

    编辑收到外审报告,两个月了迟迟不做决定,有知道原因的吗?

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2206165, encodeId=cc9d220616512, content=三天就peer review了,现在peer review一个月了也没有消息,这是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a9099638, createdName=ms4000001167903499, createdTime=Thu May 23 10:45:40 CST 2024, time=2024-05-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169145, encodeId=8c95216914575, content=有人能说下投稿状态的变化吗,里边是peer review,外边是editor appointed,多久会变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18152413432, createdName=1237f2c6m31暂无昵称, createdTime=Fri Nov 17 16:38:01 CST 2023, time=2023-11-17, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2125950, encodeId=b778212595012, content=编辑收到外审报告,两个月了迟迟不做决定,有知道原因的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Fri Apr 14 18:01:21 CST 2023, time=2023-04-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145376, encodeId=545521453e621, content=9分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Thu Jun 29 08:32:45 CST 2023, time=2023-06-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126276, encodeId=c4e121262e6f8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长,结果是好的,继续努力。 Version 2 created 24 Jan, 2023 Editorial decision: Accepted On 13 Mar, 2023 Reviews received Received 03 Feb, 2023 Reviewers agreed On 27 Jan, 2023 Reviewers invited Invitations sent on 26 Jan, 2023 Submission checks complete On 26 Jan, 2023 Submitted to Alzheimer's Research & Therapy On 24 Jan, 2023 Preprint in production at Research Square Version 1 posted 22 Jul, 2022 No new comments on your preprint Editorial decision: Major revision On 28 Dec, 2022 Reviewers agreed On 21 Dec, 2022 Reviews received Received 29 Oct, 2022 Reviewers agreed On 19 Oct, 2022 Reviewers invited Invitations sent on 25 Jul, 2022 Submission checks complete On 20 Jul, 2022 Editor assigned On 20 Jul, 2022 First submitted to Alzheimer's Research & Therapy, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:22:28 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126275, encodeId=f53321262e5ed, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:19:14 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126273, encodeId=4cf221262e346, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长了,结果是好的,继续努力<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:17:34 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1237034, encodeId=e465123e03421, content=偏重的研究方向:认知<br>经验分享:请问投稿之前需要先查重吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=XW-Tong, createdTime=Sun Aug 07 09:16:03 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104694, encodeId=8ee21104694ef, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104693, encodeId=bd7d110469301, content=如何回复期刊编辑的意见?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2023-06-29 ms9000001700710365 来自浙江省

    9分了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2206165, encodeId=cc9d220616512, content=三天就peer review了,现在peer review一个月了也没有消息,这是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a9099638, createdName=ms4000001167903499, createdTime=Thu May 23 10:45:40 CST 2024, time=2024-05-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169145, encodeId=8c95216914575, content=有人能说下投稿状态的变化吗,里边是peer review,外边是editor appointed,多久会变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18152413432, createdName=1237f2c6m31暂无昵称, createdTime=Fri Nov 17 16:38:01 CST 2023, time=2023-11-17, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2125950, encodeId=b778212595012, content=编辑收到外审报告,两个月了迟迟不做决定,有知道原因的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Fri Apr 14 18:01:21 CST 2023, time=2023-04-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145376, encodeId=545521453e621, content=9分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Thu Jun 29 08:32:45 CST 2023, time=2023-06-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126276, encodeId=c4e121262e6f8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长,结果是好的,继续努力。 Version 2 created 24 Jan, 2023 Editorial decision: Accepted On 13 Mar, 2023 Reviews received Received 03 Feb, 2023 Reviewers agreed On 27 Jan, 2023 Reviewers invited Invitations sent on 26 Jan, 2023 Submission checks complete On 26 Jan, 2023 Submitted to Alzheimer's Research & Therapy On 24 Jan, 2023 Preprint in production at Research Square Version 1 posted 22 Jul, 2022 No new comments on your preprint Editorial decision: Major revision On 28 Dec, 2022 Reviewers agreed On 21 Dec, 2022 Reviews received Received 29 Oct, 2022 Reviewers agreed On 19 Oct, 2022 Reviewers invited Invitations sent on 25 Jul, 2022 Submission checks complete On 20 Jul, 2022 Editor assigned On 20 Jul, 2022 First submitted to Alzheimer's Research & Therapy, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:22:28 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126275, encodeId=f53321262e5ed, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:19:14 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126273, encodeId=4cf221262e346, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长了,结果是好的,继续努力<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:17:34 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1237034, encodeId=e465123e03421, content=偏重的研究方向:认知<br>经验分享:请问投稿之前需要先查重吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=XW-Tong, createdTime=Sun Aug 07 09:16:03 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104694, encodeId=8ee21104694ef, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104693, encodeId=bd7d110469301, content=如何回复期刊编辑的意见?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2023-04-16 306523804 来自黑龙江省

    审稿速度:4.0 | 投稿命中率:25.0
    偏重的研究方向:FTLD
    经验分享:太漫长,结果是好的,继续努力。 Version 2 created 24 Jan, 2023 Editorial decision: Accepted On 13 Mar, 2023 Reviews received Received 03 Feb, 2023 Reviewers agreed On 27 Jan, 2023 Reviewers invited Invitations sent on 26 Jan, 2023 Submission checks complete On 26 Jan, 2023 Submitted to Alzheimer's Research & Therapy On 24 Jan, 2023 Preprint in production at Research Square Version 1 posted 22 Jul, 2022 No new comments on your preprint Editorial decision: Major revision On 28 Dec, 2022 Reviewers agreed On 21 Dec, 2022 Reviews received Received 29 Oct, 2022 Reviewers agreed On 19 Oct, 2022 Reviewers invited Invitations sent on 25 Jul, 2022 Submission checks complete On 20 Jul, 2022 Editor assigned On 20 Jul, 2022 First submitted to Alzheimer's Research & Therapy

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2206165, encodeId=cc9d220616512, content=三天就peer review了,现在peer review一个月了也没有消息,这是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a9099638, createdName=ms4000001167903499, createdTime=Thu May 23 10:45:40 CST 2024, time=2024-05-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169145, encodeId=8c95216914575, content=有人能说下投稿状态的变化吗,里边是peer review,外边是editor appointed,多久会变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18152413432, createdName=1237f2c6m31暂无昵称, createdTime=Fri Nov 17 16:38:01 CST 2023, time=2023-11-17, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2125950, encodeId=b778212595012, content=编辑收到外审报告,两个月了迟迟不做决定,有知道原因的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Fri Apr 14 18:01:21 CST 2023, time=2023-04-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145376, encodeId=545521453e621, content=9分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Thu Jun 29 08:32:45 CST 2023, time=2023-06-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126276, encodeId=c4e121262e6f8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长,结果是好的,继续努力。 Version 2 created 24 Jan, 2023 Editorial decision: Accepted On 13 Mar, 2023 Reviews received Received 03 Feb, 2023 Reviewers agreed On 27 Jan, 2023 Reviewers invited Invitations sent on 26 Jan, 2023 Submission checks complete On 26 Jan, 2023 Submitted to Alzheimer's Research & Therapy On 24 Jan, 2023 Preprint in production at Research Square Version 1 posted 22 Jul, 2022 No new comments on your preprint Editorial decision: Major revision On 28 Dec, 2022 Reviewers agreed On 21 Dec, 2022 Reviews received Received 29 Oct, 2022 Reviewers agreed On 19 Oct, 2022 Reviewers invited Invitations sent on 25 Jul, 2022 Submission checks complete On 20 Jul, 2022 Editor assigned On 20 Jul, 2022 First submitted to Alzheimer's Research & Therapy, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:22:28 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126275, encodeId=f53321262e5ed, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:19:14 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126273, encodeId=4cf221262e346, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长了,结果是好的,继续努力<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:17:34 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1237034, encodeId=e465123e03421, content=偏重的研究方向:认知<br>经验分享:请问投稿之前需要先查重吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=XW-Tong, createdTime=Sun Aug 07 09:16:03 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104694, encodeId=8ee21104694ef, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104693, encodeId=bd7d110469301, content=如何回复期刊编辑的意见?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2023-04-16 306523804 来自黑龙江省

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向:FTLD
    经验分享:
    Version 2
    created 24 Jan, 2023
    Editorial decision: Accepted
    On 13 Mar, 2023
    Reviews received
    Received 03 Feb, 2023
    Reviewers agreed
    On 27 Jan, 2023
    Reviewers invited
    Invitations sent on 26 Jan, 2023
    Submission checks complete
    On 26 Jan, 2023
    Submitted to Alzheimer's Research & Therapy
    On 24 Jan, 2023
    Preprint in production at Research Square
    Version 1
    posted 22 Jul, 2022
    No new comments on your preprint
    Editorial decision: Major revision
    On 28 Dec, 2022
    Reviewers agreed
    On 21 Dec, 2022
    Reviews received
    Received 29 Oct, 2022
    Reviewers agreed
    On 19 Oct, 2022
    Reviewers invited
    Invitations sent on 25 Jul, 2022
    Submission checks complete
    On 20 Jul, 2022
    Editor assigned
    On 20 Jul, 2022
    First submitted to Alzheimer's Research & Therapy

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2206165, encodeId=cc9d220616512, content=三天就peer review了,现在peer review一个月了也没有消息,这是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a9099638, createdName=ms4000001167903499, createdTime=Thu May 23 10:45:40 CST 2024, time=2024-05-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169145, encodeId=8c95216914575, content=有人能说下投稿状态的变化吗,里边是peer review,外边是editor appointed,多久会变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18152413432, createdName=1237f2c6m31暂无昵称, createdTime=Fri Nov 17 16:38:01 CST 2023, time=2023-11-17, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2125950, encodeId=b778212595012, content=编辑收到外审报告,两个月了迟迟不做决定,有知道原因的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Fri Apr 14 18:01:21 CST 2023, time=2023-04-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145376, encodeId=545521453e621, content=9分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Thu Jun 29 08:32:45 CST 2023, time=2023-06-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126276, encodeId=c4e121262e6f8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长,结果是好的,继续努力。 Version 2 created 24 Jan, 2023 Editorial decision: Accepted On 13 Mar, 2023 Reviews received Received 03 Feb, 2023 Reviewers agreed On 27 Jan, 2023 Reviewers invited Invitations sent on 26 Jan, 2023 Submission checks complete On 26 Jan, 2023 Submitted to Alzheimer's Research & Therapy On 24 Jan, 2023 Preprint in production at Research Square Version 1 posted 22 Jul, 2022 No new comments on your preprint Editorial decision: Major revision On 28 Dec, 2022 Reviewers agreed On 21 Dec, 2022 Reviews received Received 29 Oct, 2022 Reviewers agreed On 19 Oct, 2022 Reviewers invited Invitations sent on 25 Jul, 2022 Submission checks complete On 20 Jul, 2022 Editor assigned On 20 Jul, 2022 First submitted to Alzheimer's Research & Therapy, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:22:28 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126275, encodeId=f53321262e5ed, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:19:14 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126273, encodeId=4cf221262e346, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长了,结果是好的,继续努力<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:17:34 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1237034, encodeId=e465123e03421, content=偏重的研究方向:认知<br>经验分享:请问投稿之前需要先查重吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=XW-Tong, createdTime=Sun Aug 07 09:16:03 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104694, encodeId=8ee21104694ef, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104693, encodeId=bd7d110469301, content=如何回复期刊编辑的意见?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2023-04-16 306523804 来自黑龙江省

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向:FTLD
    经验分享:太漫长了,结果是好的,继续努力
    Version 2
    created 24 Jan, 2023
    Editorial decision: Accepted
    On 13 Mar, 2023
    Reviews received
    Received 03 Feb, 2023
    Reviewers agreed
    On 27 Jan, 2023
    Reviewers invited
    Invitations sent on 26 Jan, 2023
    Submission checks complete
    On 26 Jan, 2023
    Submitted to Alzheimer's Research & Therapy
    On 24 Jan, 2023
    Preprint in production at Research Square
    Version 1
    posted 22 Jul, 2022
    No new comments on your preprint
    Editorial decision: Major revision
    On 28 Dec, 2022
    Reviewers agreed
    On 21 Dec, 2022
    Reviews received
    Received 29 Oct, 2022
    Reviewers agreed
    On 19 Oct, 2022
    Reviewers invited
    Invitations sent on 25 Jul, 2022
    Submission checks complete
    On 20 Jul, 2022
    Editor assigned
    On 20 Jul, 2022
    First submitted to Alzheimer's Research & Therapy

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2206165, encodeId=cc9d220616512, content=三天就peer review了,现在peer review一个月了也没有消息,这是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a9099638, createdName=ms4000001167903499, createdTime=Thu May 23 10:45:40 CST 2024, time=2024-05-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169145, encodeId=8c95216914575, content=有人能说下投稿状态的变化吗,里边是peer review,外边是editor appointed,多久会变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18152413432, createdName=1237f2c6m31暂无昵称, createdTime=Fri Nov 17 16:38:01 CST 2023, time=2023-11-17, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2125950, encodeId=b778212595012, content=编辑收到外审报告,两个月了迟迟不做决定,有知道原因的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Fri Apr 14 18:01:21 CST 2023, time=2023-04-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145376, encodeId=545521453e621, content=9分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Thu Jun 29 08:32:45 CST 2023, time=2023-06-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126276, encodeId=c4e121262e6f8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长,结果是好的,继续努力。 Version 2 created 24 Jan, 2023 Editorial decision: Accepted On 13 Mar, 2023 Reviews received Received 03 Feb, 2023 Reviewers agreed On 27 Jan, 2023 Reviewers invited Invitations sent on 26 Jan, 2023 Submission checks complete On 26 Jan, 2023 Submitted to Alzheimer's Research & Therapy On 24 Jan, 2023 Preprint in production at Research Square Version 1 posted 22 Jul, 2022 No new comments on your preprint Editorial decision: Major revision On 28 Dec, 2022 Reviewers agreed On 21 Dec, 2022 Reviews received Received 29 Oct, 2022 Reviewers agreed On 19 Oct, 2022 Reviewers invited Invitations sent on 25 Jul, 2022 Submission checks complete On 20 Jul, 2022 Editor assigned On 20 Jul, 2022 First submitted to Alzheimer's Research & Therapy, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:22:28 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126275, encodeId=f53321262e5ed, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:19:14 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126273, encodeId=4cf221262e346, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长了,结果是好的,继续努力<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:17:34 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1237034, encodeId=e465123e03421, content=偏重的研究方向:认知<br>经验分享:请问投稿之前需要先查重吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=XW-Tong, createdTime=Sun Aug 07 09:16:03 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104694, encodeId=8ee21104694ef, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104693, encodeId=bd7d110469301, content=如何回复期刊编辑的意见?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2022-08-07 XW-Tong

    偏重的研究方向:认知
    经验分享:请问投稿之前需要先查重吗?

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2206165, encodeId=cc9d220616512, content=三天就peer review了,现在peer review一个月了也没有消息,这是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a9099638, createdName=ms4000001167903499, createdTime=Thu May 23 10:45:40 CST 2024, time=2024-05-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169145, encodeId=8c95216914575, content=有人能说下投稿状态的变化吗,里边是peer review,外边是editor appointed,多久会变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18152413432, createdName=1237f2c6m31暂无昵称, createdTime=Fri Nov 17 16:38:01 CST 2023, time=2023-11-17, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2125950, encodeId=b778212595012, content=编辑收到外审报告,两个月了迟迟不做决定,有知道原因的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Fri Apr 14 18:01:21 CST 2023, time=2023-04-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145376, encodeId=545521453e621, content=9分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Thu Jun 29 08:32:45 CST 2023, time=2023-06-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126276, encodeId=c4e121262e6f8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长,结果是好的,继续努力。 Version 2 created 24 Jan, 2023 Editorial decision: Accepted On 13 Mar, 2023 Reviews received Received 03 Feb, 2023 Reviewers agreed On 27 Jan, 2023 Reviewers invited Invitations sent on 26 Jan, 2023 Submission checks complete On 26 Jan, 2023 Submitted to Alzheimer's Research & Therapy On 24 Jan, 2023 Preprint in production at Research Square Version 1 posted 22 Jul, 2022 No new comments on your preprint Editorial decision: Major revision On 28 Dec, 2022 Reviewers agreed On 21 Dec, 2022 Reviews received Received 29 Oct, 2022 Reviewers agreed On 19 Oct, 2022 Reviewers invited Invitations sent on 25 Jul, 2022 Submission checks complete On 20 Jul, 2022 Editor assigned On 20 Jul, 2022 First submitted to Alzheimer's Research & Therapy, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:22:28 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126275, encodeId=f53321262e5ed, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:19:14 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126273, encodeId=4cf221262e346, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长了,结果是好的,继续努力<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:17:34 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1237034, encodeId=e465123e03421, content=偏重的研究方向:认知<br>经验分享:请问投稿之前需要先查重吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=XW-Tong, createdTime=Sun Aug 07 09:16:03 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104694, encodeId=8ee21104694ef, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104693, encodeId=bd7d110469301, content=如何回复期刊编辑的意见?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-28 衣谷

    回复评审的意见和期刊编辑的意见有什么不同?

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2206165, encodeId=cc9d220616512, content=三天就peer review了,现在peer review一个月了也没有消息,这是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a9099638, createdName=ms4000001167903499, createdTime=Thu May 23 10:45:40 CST 2024, time=2024-05-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2169145, encodeId=8c95216914575, content=有人能说下投稿状态的变化吗,里边是peer review,外边是editor appointed,多久会变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18152413432, createdName=1237f2c6m31暂无昵称, createdTime=Fri Nov 17 16:38:01 CST 2023, time=2023-11-17, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=2125950, encodeId=b778212595012, content=编辑收到外审报告,两个月了迟迟不做决定,有知道原因的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Fri Apr 14 18:01:21 CST 2023, time=2023-04-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2145376, encodeId=545521453e621, content=9分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Thu Jun 29 08:32:45 CST 2023, time=2023-06-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126276, encodeId=c4e121262e6f8, content=审稿速度:4.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长,结果是好的,继续努力。 Version 2 created 24 Jan, 2023 Editorial decision: Accepted On 13 Mar, 2023 Reviews received Received 03 Feb, 2023 Reviewers agreed On 27 Jan, 2023 Reviewers invited Invitations sent on 26 Jan, 2023 Submission checks complete On 26 Jan, 2023 Submitted to Alzheimer's Research & Therapy On 24 Jan, 2023 Preprint in production at Research Square Version 1 posted 22 Jul, 2022 No new comments on your preprint Editorial decision: Major revision On 28 Dec, 2022 Reviewers agreed On 21 Dec, 2022 Reviews received Received 29 Oct, 2022 Reviewers agreed On 19 Oct, 2022 Reviewers invited Invitations sent on 25 Jul, 2022 Submission checks complete On 20 Jul, 2022 Editor assigned On 20 Jul, 2022 First submitted to Alzheimer's Research & Therapy, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:22:28 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126275, encodeId=f53321262e5ed, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:19:14 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2126273, encodeId=4cf221262e346, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:FTLD<br>经验分享:太漫长了,结果是好的,继续努力<br>Version 2<br>created 24 Jan, 2023<br>Editorial decision: Accepted<br>On 13 Mar, 2023<br>Reviews received<br>Received 03 Feb, 2023<br>Reviewers agreed<br>On 27 Jan, 2023<br>Reviewers invited<br>Invitations sent on 26 Jan, 2023<br>Submission checks complete<br>On 26 Jan, 2023<br>Submitted to Alzheimer's Research & Therapy<br>On 24 Jan, 2023<br>Preprint in production at Research Square<br>Version 1<br>posted 22 Jul, 2022<br>No new comments on your preprint<br>Editorial decision: Major revision<br>On 28 Dec, 2022<br>Reviewers agreed<br>On 21 Dec, 2022<br>Reviews received<br>Received 29 Oct, 2022<br>Reviewers agreed<br>On 19 Oct, 2022<br>Reviewers invited<br>Invitations sent on 25 Jul, 2022<br>Submission checks complete<br>On 20 Jul, 2022<br>Editor assigned<br>On 20 Jul, 2022<br>First submitted to Alzheimer's Research & Therapy<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Apr 16 15:17:34 CST 2023, time=2023-04-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1237034, encodeId=e465123e03421, content=偏重的研究方向:认知<br>经验分享:请问投稿之前需要先查重吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fd45695826, createdName=XW-Tong, createdTime=Sun Aug 07 09:16:03 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104694, encodeId=8ee21104694ef, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104693, encodeId=bd7d110469301, content=如何回复期刊编辑的意见?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-27 ms6000000264964247

    如何回复期刊编辑的意见?

    1

    展开1条回复
共27条页码: 1/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分